SITSA Act

H.R.767-Stop, Observe, Ask, and Respond (SOAR) to Health and Wellness Act of 2017 H.R.1057-Synthetics Trafficking and Overdose Prevention Act of 2017 H.R.1492-Medical Controlled Substances Transportation Act of 2017 H.R.2200-Frederick Douglass Trafficking Victims Prevention and Protection Reauthorization Act of 2017 H.R.2851-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 H.R.4922-Stopping Overdoses of Fentanyl Analogues Act S.372-Synthetics Trafficking and Overdose Prevention Act of 2017 S.256-SOAR to Health and Wellness Act of 2017 S.1327-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 S.1553-Stopping Overdoses of Fentanyl Analogues Act

Client expense: $402,721 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.6-Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act H.R.1057-Synthetics Trafficking and Overdose Prevention Act of 2017 H.R.1492-Medical Controlled Substances Transportation Act of 2017 H.R.2851-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 H.R.3545-Overdose Prevention and Patient Safety (OPPS) Act H.R.4922-Stopping Overdoses of Fentanyl Analogues Act H.R.5176-Preventing Overdoses While in Emergency Rooms Act of 2018 H.R.5197-Alternatives to Opioids (ALTO) in the Emergency Department Act H.R.5531-Opioid Emergency Response Act H.R.5558-Alternatives to Opioids Prescribing Act H.R.6082-Overdose Prevention and Patient Safety (OPPS) Act S.372-Synthetics Trafficking and Overdose Prevention Act of 2017 S.1327-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 S.1553-Stopping Overdoses of Fentanyl Analogues Act S.2516-Alternatives to Opioids (ALTO) in the Emergency Department Act S.2609-Recovery Coaches Offer Addiction Counseling and Healing (COACH) Act S.2610-Preventing Overdoses While in Emergency Departments Act of 2018 S.2680-Opioid Crisis Response Act of 2018

Client expense: $402,721 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 62, the Gun Violence Reduction Resources Act, would authorize the hiring of an additional 200 agents and investigators for the Bureau of Alcohol, Tobacco, Firearms and Explosives in the U.S. Department of Justice; H.R. 115/S. 1085, the Thin Blue Line Act, would increase the penalty for offenders who kill or attempt to kill law enforcement or other public safety officers; H.R. 426/S. 1087, the Protecting Lives Using Surplus (PLUS) Equipment Act, which would restore all Federal equipment assistance programs to State and local law enforcement which were restricted by Executive Order 13688; H.R. 613/S. 1084, the Lieutenant Osvaldo Albarati Correctional Officer Self-Protection Act, would direct the Bureau of Prisons to make secure firearms storage areas accessible to employees at all of its facilities; H.R. 622, the Local Law Enforcement for Local Lands Act, would terminate the law enforcement functions of the U.S. Forest Service and the Bureau of Land Management; H.R. 664, the Stem the Tide of Overdose Prevalence from Opiate Drugs (STOP OD) Act, would aim to reduce the curb the number of overdoses due to synthetic fentanyl and helps equip law enforcement officers with naloxone; H.R. 909/S. 322, the Pet and Women Safety (PAWS) Act, would expand existing Federal protections to the pets of domestic abuse victims and establish a grant program to assist victims and their pets when they leave their abusers; H.R. 1039/S. 367, the Probation Officer Protection Act, which would amend section 3606 of Title 18, United States Code, to grant probation officers authority to arrest hostile third parties who obstruct or impede a probation officer in the performance of official duties; H.R. 1057/S. 372, the Synthetics Trafficking and Overdose Prevention (STOP) Act would close the loophole and allow U.S Border and Customs Protections to effectively enforce customs laws that will stop the flow of deadly synthetic drugs into our communities from China; H.R. 1494/S. 654, the Preventing Animal Cruelty and Torture Act which would provide criminal penalty for those who engage in animal crushing, as well as for those who create or distribute such films; H.R. 1498, the End Racial Profiling Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search-absent an eyewitness description-and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; H.R. 1636, the School Safety Act, which would reauthorize and expand the Secure Our Schools program administered by the Office of Community Oriented Policing Services (COPS); H.R. 1732, the Synthetic Drug Control Act, which would enhance the ability of law enforcement to combat synthesized drugs by amending the Controlled Substances Act to clarify how controlled substance analogues are to be regulated; H.R. 1761, the Protection Against Child Exploitation Act, which would close an existing loophole in current statute by clarifying certain definitions in child pornography law; H.R. 1886/S. 573, the National Criminal Justice Commission Act, which would establish National Criminal Justice Commission to study the nations criminal justice systems; H.R. 1979, the No More Tulias: Drug Law Enforcement Evidentiary Standards Improvement Act, which would significantly limit States who fund anti-drug task forces from receiving Federal funding from the Edward J. Byrne Memorial Justice Assistant Grants program; H.R. 2213, the Anti-Bordering Corruption Reauthorization Act, which would improve the ability of the U.S. Customs and Border Patrol to hire new officers; H.R. 2437/S. 1134, the Back the Blue Act, which contains a number of amendments to Federal law expanding the death penalty for persons who kill law enforcement officers, restrictions on habeas corpus, limitation on recovery of damages incurred during an arrest as well as two amendments to the Law Enforcement Officers Safety Act (LEOSA) with respect to magazine capacity and the Guns Free School Zones Act; H.R. 2513, the Police Officers Protecting Children Act, which would add qualified active and retired law enforcement officers, as defined by the Law Enforcement Officers Safety Act (LEOSA), to the list of exemptions to the Guns Free School Zones Act; H.R. 2561, the Protecting Police Officers of the Law in Civilian Establishments Act, which would clarify that existing Federal laws which prohibit the carriage of firearms onto Federal property like post offices, Social Security offices and Veterans Affairs offices do not apply to law enforcement officers in uniform; H.R. 2851/S. 1327, the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act, would amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated by allowing the Attorney General to add synthetic analogues either temporarily/permanently to Schedule A; H.R. 3003, Section 2, the "No Sanctuary for Criminals Act, which would penalize law enforcement agencies by withholding Federal funding from so-called sanctuary cities; H.R. 3089/S. 1454/S. 1717, the Corporate Transparency Act, would require the Federal government to collect beneficial ownership information for corporations and limited liability companies unless the State already collects this information; H.R. 3790/S. 1854, the Federal Firearms Licensee Protection Act, which would increase penalties on those who burglarize or rob a Federal Firearms Licensee; H.R. 4471/S. 2492, the NICS Denial Notification Act, would require the U.S. Department of Justice to notify State and local law enforcement agencies if a prohibited person attempts to purchase a firearm in their jurisdiction; H.R. 4768/S. 2715, the National Strategy for Combating the Financing of Transnational Criminal Organizations Act, which would codify an existing Executive Order and direct the Federal government to develop a national strategy to combat transnational criminal organizations; H.R. 4854/S. 2345, the Justice Served Act, which will increase the capacity of prosecutors to address the backlog of violent crime cases involving suspects identified through DNA evidence; H.R. 5060, the Heroes Lesley Zerebney and Gilbert Vega First Responders Survivors Support Act, which would increase the amount of the death benefit provide by the Public Safety Officers benefits (PSOB) program as well as other benefits administered by the PSOB; H.R. 5219, the Opioid Prescription Verification Act, which would require retail sellers of opioids to verify the identity of the purchaser; H.R. 5682 (as introduced), the Formerly Incarcerated Reenter Society Transformed Safely Transitioning Every Person (FIRST STEP) Act, which may result in the premature release of thousands of convicted offenders; H.R. 5698/S. 2794, the Protect and Serve Act, which would make it a Federal crime to target a law enforcement with an assault that results in seriously bodily harm or death; H.R. 5788, the Securing the International Mail Against Opioids Act, which would close the loophole and allow U.S Custom and Border Protection to effectively enforce customs laws that will stop the flow of deadly synthetic drugs into our communities from China; H.R. 5871/S. 2763, the "Providing Officers with Electronic Resources (POWER) Act, which would establishes a grant program to be administered by the Office of Community Oriented Policing Services (COPS) in order to provide State and local law enforcement agencies with portable chemical screening devices to detect dangerous synthetic opioids and other drugs; S. 207, the Synthetic Abuse and Labeling of Toxic Substances (SALTS) Act, would close the existing loophole for the manufacturers on analogue drug sales and distribution; S. 318, the COPS Improvement Act, would reauthorize the Office of Community Oriented Policing Services (COPS) and improve its existing hiring program; S. 446, the Constitutional Concealed Carry Reciprocity Act, which would allow any civilian concealed carry permit holder to travel to any other State issuing concealed carry permits without any training or safety requirements; S. 739, the Protecting Kids from Candy-Flavored Drugs Act, would impose increased prison sentences on adults who manufacture, create, distribute, or possess with the intent to distribute a controlled substance that is appealing to kids, whether designed or flavored; S. 748, the Protecting the Rights of Families and Immigrants Who Legally Entered From Detention (PROFILED) Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search, absent an eyewitness description, and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; S. 1241, the Combating Money Laundering, Terrorist Financing, and Counterfeiting Act, which would update and strengthen Federal laws to combat money laundering and provide law enforcement with additional tools to restrict the ability of criminals to profit from their crimes; S. 1311, the Abolish Human Trafficking Act, reauthorizes parts of the Trafficking Victims Protection Act and expand the authority of State and local agencies to obtain wiretap warrants for trafficking investigations; S. 1312, the Trafficking Victims Protection Act, would help prevent human trafficking by promoting training for law enforcement and school resource officers through the Office of Community Oriented Policing Services (COPS) to better identify and respond to human trafficking victims; S. 1327, the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act, would amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated by allowing the Attorney General to add synthetic analogues either temporarily/permanently to Schedule A; S. 1666, the "Helping Overcome Trauma for Children Alone in Rear Seats (HOTCARS) Act, which would direct the U.S. Department of Transportation to implement a rule requiring vehicles to notify drivers if a child or other passenger has been inadvertently left behind; S. 1781, the National White Collar Crime Control Act, which would reauthorize grant programs to law enforcement to combat white collar crimes; S. 2389, Erics Law, which would amend current law to allow Federal prosecutors to impanel a second jury for the sentencing phase of capital cases; S. 2715, the Criminal Organizations Narcotics, Finance, Resources, Operations and Network Targeting (CONFRONT) Act, which would codify an existing Executive Order and direct the Federal government to develop a national strategy to combat transnational criminal organizations; S. 2759, the EAGLES Act, which would reauthorize the National Threat Asessment Center (NTAC) within the U.S. Department of Homeland Security; S. 2774, which would reauthorize the Office of Community Oriented Policing Services (COPS) within the U.S. Department of Justice through 2023; S. 2789, the "Substance Abuse Prevention Act, which would reauthorize the Office of National Drug Control Policy and the programs it administers; S. 2973, the Kelsey Smith Act, which would require telephone companies and wireless carriers to disclose cell-site location data without a warrant in certain exigent circumstances; Legislation which would protect the personal information of law enforcement officers and their families from public access; Legislation or amendments that would have the effect of weakening PL 106-185, the Civil Asset Forfeiture Reform Act of 2000; Legislation which would create or fund civilian review boards of law enforcement at any level of government; and Legislation which would further normalize relations with Cuba until that nation ceases to be a safe harbor for cop-killers and other fugitives.

Client expense: $55,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, White House Office

Public Law 115-245, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Provisions relating to NIH, and drug abuse and treatment Drug abuse research and treatment related issues: H.R.1732, Synthetic Drug Control Act of 2017 H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA) H.R.3391, Medical Marijuana Research Act of 2017 H.R.4825/S.1803, Marijuana Effective Drug Studies (MEDS) Act of 2017 S.2260, Opioids and STOP Pain Initiative Act S.2004, Combating the Opioid Epidemic Act H.R.5298, Modernizing Drug Enforcement Act of 2018 Public Law 115-271, SUPPORT for Patients and Communities Act S.1276, Cannabidiol Research Expansion Act H.R.5634, Medical Cannabis Research Act of 2018 Public Law 115-334, Agriculture Improvement Act of 2018, Hemp related provision

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R. 714 Use of Medicinal Marihuana H.R. 715 Rescheduling of Marihuana H.R. 975 Controlled Substances Act Application to Marihuana H.R. 1781 Synthetic Opioids H.R. 1824 Federal and State Marijuana Policy Gap Reduction S. 581 Opioids Addiction Information in Medical Records S. 780 Federal and State Marijuana Policy Gap Reduction H.R. 2020 Rescheduling of Marijuana H.R. 2063 Opioid Dispensary Registration Training Condition S. 1078 FDA Opioid Approval Procedures S. 1079 FDA Opioid Approval and Revocation S. 1327 Controlled Substance Analogues Regulation H.R. 3374 Drunk Driving H.R. 3534 State Legalized Marijuana S. 1553 Schedule 1 Controlled Substances S. 1554 Controlled Substance Continuing Education S. 1689 Controlled Substances Act H.R. 3964 Registration Requirements for Prescribers of Opioids H.R. 4482 Opioid Abuse and Addiction S. 2008 Opioid Epidemic and Drug Sample Backlogs H.R. 4903 Opioid Usage Reduction Best Practices Study H.R. 4922 Fentanyl Analogues H.R. 5109 Opioid Epidemic Distribution of Resources S. 2437 Opioid Grant Program S. 2440 Opioid Epidemic S. 2535 Opioid Quotas H.R. 5473 Alternative Methods for Data Collection H.R. 5581 Prescribers of Controlled Substances H.R. 5590 Medicare and Opioid Addictions H.R. 5723 Medicare Payment Advisory Commission H.R. 5782 Pharmaceutical Company Accountability S. 2680 Opioid Crisis S. 2691 Pharmaceutical Companies and Illegal Marketing S. 2729 Prevention of Prescription Opioid Misuse S. 2838 Reporting Information on Distribution of Opioids S. 2848 Controlled Substances and Alcohol Testing H.R. 6491 Reporting of Information on Distribution of Opioids H.R. 6608 Prescription Drug Monitoring Programs Data Collection H.R. 5812 Controlled Substance Overdose Prevention Activities

Client expense: $1,030,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Natl Credit Union Administration (NCUA), Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)

H.R.5682 / S.2795 - FIRST STEP Act H.R.2851 / S.1327 - SITSA Act H.R.2899 / S.3635 - Second Chance Reauthorization Act of 2017 H.R.254 - REAL Act of 2017 H.R.1809 - Juvenile Justice Reform Act of 2017 S. 1917 - Sentencing Reform and Corrections Act of 2017, all provisions S. 860 - Juvenile Justice and Delinquency Prevention Reauthorization Act of 2017, all provisions S.1856 / H.R.1556 - Stop Militarizing Law Enforcement Act S.827 / H.R.1906 - REDEEM Act S.756 - FIRST STEP Act (vehicle that became law) S.3635 - Second Chance Reauthorization Act of 2018 Package of campaign finance reforms as yet to be introduced in the House of Representatives

Client expense: $1,000,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Stop the Importation and Trafficking of Synthetic Analogues Act (S. 1327, H.R. 2851); NDAA (H.R. 5515); Mens Rea Reform Act (S. 3118); House Farm Bill (H.R. 2) - provisions re. SNAP; Senate Transportation and Housing (THUD) appropriations bill (S. 3023) - provision re: individuals with certain convictions and public housing benefits; Consumer Data Protection Act of 2018 (Wyden discussion draft); money laundering; First Step Act (S. 3649) - all provisions; pretrial release/bail

Client expense: $15,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 5682/S. 3649/S. 756, First Step Act (prison and sentencing reform); mandatory minimum sentencing reform; H.R. 2851/S. 1327 SITSA Act (re: new schedules and sentences for drug analogues; USSC priorities; S. 3588, PREP Act (Prison education bill); H.R. 6697/S. 3335, Restoring the Armed Career Criminal Act (expands existing mandatory minimums); H.R. 7113, Combat Violent Crime Act (expands existing mandatory minimums); oversight of BOP

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 62, the Gun Violence Reduction Resources Act, would authorize the hiring of an additional 200 agents and investigators for the Bureau of Alcohol, Tobacco, Firearms and Explosives in the U.S. Department of Justice; H.R. 115/S. 1085, the Thin Blue Line Act, would increase the penalty for offenders who kill or attempt to kill law enforcement or other public safety officers; H.R. 426/S. 1087, the Protecting Lives Using Surplus (PLUS) Equipment Act, which would restore all Federal equipment assistance programs to State and local law enforcement which were restricted by Executive Order 13688; H.R. 613/S. 1084, the Lieutenant Osvaldo Albarati Correctional Officer Self-Protection Act, would direct the Bureau of Prisons to make secure firearms storage areas accessible to employees at all of its facilities; H.R. 622, the Local Law Enforcement for Local Lands Act, would terminate the law enforcement functions of the U.S. Forest Service and the Bureau of Land Management; H.R. 664, the Stem the Tide of Overdose Prevalence from Opiate Drugs (STOP OD) Act, would aim to reduce the curb the number of overdoses due to synthetic fentanyl and helps equip law enforcement officers with naloxone; H.R. 909/S. 322, the Pet and Women Safety (PAWS) Act, would expand existing Federal protections to the pets of domestic abuse victims and establish a grant program to assist victims and their pets when they leave their abusers; H.R. 1039/S. 367, the Probation Officer Protection Act, which would amend section 3606 of Title 18, United States Code, to grant probation officers authority to arrest hostile third parties who obstruct or impede a probation officer in the performance of official duties; H.R. 1057/S. 372, the Synthetics Trafficking and Overdose Prevention (STOP) Act would close the loophole and allow U.S Border and Customs Protections to effectively enforce customs laws that will stop the flow of deadly synthetic drugs into our communities from China; H.R. 1494/S. 654, the Preventing Animal Cruelty and Torture Act which would provide criminal penalty for those who engage in animal crushing, as well as for those who create or distribute such films; H.R. 1498, the End Racial Profiling Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search-absent an eyewitness description-and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; H.R. 1636, the School Safety Act, which would reauthorize and expand the Secure Our Schools program administered by the Office of Community Oriented Policing Services (COPS); H.R. 1732, the Synthetic Drug Control Act, which would enhance the ability of law enforcement to combat synthesized drugs by amending the Controlled Substances Act to clarify how controlled substance analogues are to be regulated; H.R. 1761, the Protection Against Child Exploitation Act, which would close an existing loophole in current statute by clarifying certain definitions in child pornography law; H.R. 1886/S. 573, the National Criminal Justice Commission Act, which would establish National Criminal Justice Commission to study the nations criminal justice systems; H.R. 1979, the No More Tulias: Drug Law Enforcement Evidentiary Standards Improvement Act, which would significantly limit States who fund anti-drug task forces from receiving Federal funding from the Edward J. Byrne Memorial Justice Assistant Grants program; H.R. 2213, the Anti-Bordering Corruption Reauthorization Act, which would improve the ability of the U.S. Customs and Border Patrol to hire new officers; H.R. 2437/S. 1134, the Back the Blue Act, which contains a number of amendments to Federal law expanding the death penalty for persons who kill law enforcement officers, restrictions on habeas corpus, limitation on recovery of damages incurred during an arrest as well as two amendments to the Law Enforcement Officers Safety Act (LEOSA) with respect to magazine capacity and the Guns Free School Zones Act; H.R. 2513, the Police Officers Protecting Children Act, which would add qualified active and retired law enforcement officers, as defined by the Law Enforcement Officers Safety Act (LEOSA), to the list of exemptions to the Guns Free School Zones Act; H.R. 2561, the Protecting Police Officers of the Law in Civilian Establishments Act, which would clarify that existing Federal laws which prohibit the carriage of firearms onto Federal property like post offices, Social Security offices and Veterans Affairs offices do not apply to law enforcement officers in uniform; H.R. 2851/S. 1327, the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act, would amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated by allowing the Attorney General to add synthetic analogues either temporarily/permanently to Schedule A; H.R. 3003, Section 2, the "No Sanctuary for Criminals Act, which would penalize law enforcement agencies by withholding Federal fudning from so-called sanctuary cities; H.R. 3089/S. 1454/S. 1717, the Corporate Transparency Act, would require the Federal government to collect beneficial ownership information for corporations and limited liability companies unless the State already collects this information; H.R. 3790/S. 1854, the Federal Firearms Licensee Protection Act, which would increase penalties on those who burglarize or rob a Federal Firearms Licensee; H.R. 4471/S. 2492, the NICS Denial Notification Act, would require the U.S. Department of Justice to notify State and local law enforcement agencies if a prohibited person attempts to purchase a firearm in their jurisdiction; H.R. 4768/S. 2715, the National Strategy for Combating the Financing of Transnational Criminal Organizations Act, which would codify an existing Executive Order and direct the Federal government to develop a national strategy to combat transnational criminal organizations; H.R. 4854/S. 2345, the Justice Served Act, which will increase the capacity of prosecutors to address the backlog of violent crime cases involving suspects identified through DNA evidence; H.R. 5060, the Heroes Lesley Zerebney and Gilbert Vega First Responders Survivors Support Act, which would increase the amount of the death benefit provide by the Public Safety Officers benefits (PSOB) program as well as other benefits administered by the PSOB; H.R. 5219, the Opioid Prescription Verification Act, which would require retail sellers of opioids to verify the identity of the purchaser; H.R. 5682 (as introduced), the Formerly Incarcerated Reenter Society Transformed Safely Transitioning Every Person (FIRST STEP) Act, which may result in the premature release of thousands of convicted offenders; H.R. 5698/S. 2794, the Protect and Serve Act, which would make it a Federal crime to target a law enforcement with an assault that results in seriously bodily harm or death; H.R. 5788, the Securing the International Mail Against Opioids Act, which would close the loophole and allow U.S Custom and Border Protection to effectively enforce customs laws that will stop the flow of deadly synthetic drugs into our communities from China; H.R. 5871/S. 2763, the "Providing Officers with Electronic Resources (POWER) Act, which would establishes a grant program to be administered by the Office of Community Oriented Policing Services (COPS) in order to provide State and local law enforcement agencies with portable chemical screening devices to detect dangerous synthetic opioids and other drugs; S. 207, the Synthetic Abuse and Labeling of Toxic Substances (SALTS) Act, would close the existing loophole for the manufacturers on analogue drug sales and distribution; S. 318, the COPS Improvement Act, would reauthorize the Office of Community Oriented Policing Services (COPS) and improve its existing hiring program; S. 446, the Constitutional Concealed Carry Reciprocity Act, which would allow any civilian concealed carry permit holder to travel to any other State issuing concealed carry permits without any training or safety requirements; S. 739, the Protecting Kids from Candy-Flavored Drugs Act, would impose increased prison sentences on adults who manufacture, create, distribute, or possess with the intent to distribute a controlled substance that is appealing to kids, whether designed or flavored; S. 748, the Protecting the Rights of Families and Immigrants Who Legally Entered From Detention (PROFILED) Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search, absent an eyewitness description, and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; S. 1241, the Combating Money Laundering, Terrorist Financing, and Counterfeiting Act, which would update and strengthen Federal laws to combat money laundering and provide law enforcement with additional tools to restrict the ability of criminals to profit from their crimes; S. 1311, the Abolish Human Trafficking Act, reauthorizes parts of the Trafficking Victims Protection Act and expand the authority of State and local agencies to obtain wiretap warrants for trafficking investigations; S. 1312, the Trafficking Victims Protection Act, would help prevent human trafficking by promoting training for law enforcement and school resource officers through the Office of Community Oriented Policing Services (COPS) to better identify and respond to human trafficking victims; S. 1327, the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act, would amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated by allowing the Attorney General to add synthetic analogues either temporarily/permanently to Schedule A; S. 1666, the "Helping Overcome Trauma for Children Alone in Rear Seats (HOTCARS) Act, which would direct the U.S. Department of Transportation to implement a rule requiring vehicles to notify drivers if a child or other passenger has been inadvertently left behind; S. 1781, the National White Collar Crime Control Act, which would reauthorize grant programs to law enforcement to combat white collar crimes; S. 2389, Erics Law, which would amend current law to allow Federal prosecutors to impanel a second jury for the sentencing phase of capital cases; S. 2715, the Criminal Organizations Narcotics, Finance, Resources, Operations and Network Targeting (CONFRONT) Act, which would codify an existing Executive Order and direct the Federal government to develop a national strategy to combat transnational criminal organizations; S. 2759, the EAGLES Act, which would reauthorize the National Threat Asessment Center (NTAC) within the U.S. Department of Homeland Security; S. 2774, which would reauthorize the Office of Community Oriented Policing Services (COPS) within the U.S. Department of Justice through 2023; S. 2789, the "Substance Abuse Prevention Act, which would reauthorize the Office of National Drug Control Policy and the programs it administers; S. 2973, the Kelsey Smith Act, which would require telephone companies and wireless carriers to disclose cell-site location data without a warrant in certain exigent circumstances; Legislation which would protect the personal information of law enforcement officers and their families from public access; Legislation or amendments that would have the effect of weakening PL 106-185, the Civil Asset Forfeiture Reform Act of 2000; Legislation which would create or fund civilian review boards of law enforcement at any level of government; and Legislation which would further normalize relations with Cuba until that nation ceases to be a safe harbor for cop-killers and other fugitives.

Client expense: $55,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, White House Office

H.R. 6: SUPPORT for Patients and Communities Act - To provide for opioid use disorder prevention, recovery, and treatment, and for other purposes H.R. 449: Synthetic Drug Awareness Act: Provisions related to synthetic drug report H.R. 749: Lower Drug Costs through Competition Act - Provisions related to generic drug approvals H.R. 878: Right to Try Act of 2017 - Provisions related to use of unapproved medical products by patients with a terminal illness H.R. 1245: Affordable and Safe Prescription Drug Importation Act - Provisions related to importation H.R. 1480: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation H.R. 1628: American Health Care Act of 2017 - Provisions related to the biopharmaceutical industry including repeal of brand pharmaceutical manufacturer fee and individual and employer mandates, insurance affordability provisions, and Medicaid reforms H.R. 1776: Improving Access to Affordable Prescription Drugs Act - Provisions related to drug pricing H.R. 2025: Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 - Provisions related to labeling information describing abuse-deterrent properties H.R. 2051: FAST Generics Act of 2017 - Provisions related to REMS and limited distribution systems H.R. 2063: Opioid Preventing Abuse through Continuing Education (PACE) Act of 2017 - Provisions related to prescriber training H.R. 2212: CREATES Act of 2017 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 4710: 340B Protecting Access for the Underserved and Safety-net Entities Act or PAUSE Act - Provisions related to the 340B program H.R. 4482: Opioid Abuse Deterrence, Research, and Recovery Act of 2017 - Provisions related to prescriber requirements H.R. 5041: The Safe Disposal of Unused Medication Act - Provisions related to drug disposal H.R. 5202: Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 - Provisions related to drug delivery H.R. 5228: SCREEN Act - Provisions related to drug recall authority H.R. 5311: CARA 2.0 Act of 2018 - Provisions to reauthorize and expand the Comprehensive Addiction and Recovery Act H.R. 5582: Abuse Deterrent Access Act of 2018 H.R. 5598: 340B Optimization Act - Provisions related to transparency in the 340B program H.R. 5687: SOUND Disposal and Packaging Act - Provisions related to packaging and disposal methods with respect to certain drugs H.R. 5752: Stop Illicit Importation Act of 2018 - Provisions related to importation H.R. 5788: Synthetics Trafficking and Overdose Prevention Act of 2018 or STOP Act of 2018 H.R. 5803: SAFETY Act of 2018 - Provisions related to drug approval H.R. 6143: Patient Right to Know Drug Prices Act - Provisions related to drug pricing H. Res. 949: Providing for consideration of the bill (H.R. 6) to provide for opioid use disorder prevention, recovery, and treatment, and for other purposes; providing for consideration of the bill (H.R. 5797) to amend title XIX of the Social Security Act to allow States to provide under Medicaid services for certain individuals with opioid use disorders in institutions for mental diseases; and providing for consideration of the bill (H.R. 6082) to amend the Public Health Service Act to protect the confidentiality of substance use disorder patient records S. 64: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation S. 92: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation S. 469: Affordable and Safe Prescription Drug Importation Act - Provisions related to importation S. 771: Improving Access to Affordable Prescription Drugs Act - Provisions related to drug pricing S. 974: CREATES Act of 2017 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems S. 1131: Fair Accountability and Innovative Research Drug Pricing Act of 2017 - Provisions related to drug pricing S. 1327: SITSA Act - Provisions related to controlled substances S. 2157: Drug-Price Transparency in Communications Act S. 2312: HELP Act - Provisions related to 340B program S. 2453: Ensuring the Value of the 340B Program Act of 2018 - Provisions to increase transparency in the 340B program S. 2553: Know the Lowest Price Act of 2018 - Provisions related to drug pricing S. 2554: Patient Right to Know Drug Prices Act - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees S. 2665: A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety S. 3519: A bill to establish a process for the Food and Drug Administration to determine whether to modify the labeling of drugs whose labeling may be outdated, including drugs with accepted uses that are not reflected in the approved labeling Drug cost and pricing policy issues Transparency policy issues Drug importation and counterfeiting policy issues Prescription drug take back and secure disposal policy issues Policy issues related to prescription drug abuse and opioids Expanded access policy issues Generic drug approval process policy issues High deductible health plans/HSA policy issues Sharing of truthful and non-misleading information about medicines with healthcare professionals and payors Risk Evaluation and Mitigation Strategy (REMS) policy issues FDA modernization policy issues PDUFA implementation policy issues 340B drug discount program policy issues Bipartisan Budget Act of 2018 (Public Law 115-123) - Part D provisions Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug compounding policy issues including federal oversight of compounded drugs Cancer drug vial size policy issues TRICARE pharmacy pilot program Drug shortages policy issues Reauthorization of the Pandemic and All-Hazards Preparedness Act Request for Information: HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs (RIN 0991-ZA49) HR6, SUPPORT for Patients and Communities Act, Provisions related to BBA technical correction (Part D) HR 394/S 85 - Restoring Access to Medication Act of 2017Vaccine manufacturing practices HR 4297/S2103, Protecting Seniors Through Immunization Act; HR4993/S3253, Vaccine Access Improvement Act; HR 5333 - Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018Durbin/Grassley Amendment HR 6199 - Restoring Access to Medication and Modernizing Health Savings Accounts Act of 2018 H.R.6378 To reauthorize certain programs under the Pandemic and All-Hazards Preparedness Reauthorization Act S 2315 - Over-the-Counter Drug Safety, Innovation, and Reform Act' S.2852 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018

Client expense: $1,130,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 6: SUPPORT for Patients and Communities Act - To provide for opioid use disorder prevention, recovery, and treatment, and for other purposes H.R. 449: Synthetic Drug Awareness Act: Provisions related to synthetic drug report H.R. 749: Lower Drug Costs through Competition Act - Provisions related to generic drug approvals H.R. 1245: Affordable and Safe Prescription Drug Importation Act - Provisions related to importation H.R. 1480: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation H.R. 1628: American Health Care Act of 2017 - Provisions related to the biopharmaceutical industry including repeal of brand pharmaceutical manufacturer fee and individual and employer mandates, insurance affordability provisions, and Medicaid reforms H.R. 1776: Improving Access to Affordable Prescription Drugs Act - Provisions related to drug pricing H.R. 2025: Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 - Provisions related to labeling information describing abuse-deterrent properties H.R. 2051: FAST Generics Act of 2017 - Provisions related to REMS and limited distribution systems H.R. 2063: Opioid Preventing Abuse through Continuing Education (PACE) Act of 2017 - Provisions related to prescriber training H.R. 2212: CREATES Act of 2017 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 2851: Stop Importation and Trafficking of Synthetic Analogues (SITSA) Act - Provisions related to controlled substances H.R. 3545: Overdose Prevention and Patient Safety Act - Provisions related to substance use disorder records H.R. 3692: Addiction Treatment Access Improvement Act of 2017 - Provisions related to medication assisted treatment (MAT) access H.R. 4275: Empowering Pharmacists in the Fight Against Opioid Abuse Act - Provisions related to pharmacist education H.R. 4284: Indexing Narcotics, Fentanyl, and Opioids (INFO) Act of 2018 - Provisions related to substance use disorder information H.R. 4710: 340B Protecting Access for the Underserved and Safety-net Entities Act or PAUSE Act - Provisions related to the 340B program H.R. 4482: Opioid Abuse Deterrence, Research, and Recovery Act of 2017 - Provisions related to prescriber requirements H.R. 5002: Advancing Cutting Edge Research Act - Provisions related to non-addiction pain medication H.R. 5009: Jessies Law - Provisions related to patient information H.R. 5041: The Safe Disposal of Unused Medication Act - Provisions related to drug disposal H.R. 5102: Substance Use Disorder Workforce Loan Repayment Act of 2018 - Provisions related to loan repayment program H.R. 5202: Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 - Provisions related to drug delivery H.R. 5228: SCREEN Act - Provisions related to drug recall authority H.R. 5311: CARA 2.0 Act of 2018 - Provisions to reauthorize and expand the Comprehensive Addiction and Recovery Act H.R. 5327: Comprehensive Opioid Recovery Centers Act of 2018 - Provisions related to opioid recovery center grants H.R. 5329: Poison Center Network Enhancement Act of 2018 - Provisions related to national poison center funding and other prevention funding H.R. 5582: Abuse Deterrent Access Act of 2018 H.R. 5598: 340B Optimization Act - Provisions related to transparency in the 340B program H.R. 5687: SOUND Disposal and Packaging Act - Provisions related to packaging and disposal methods with respect to certain drugs H.R. 5752: Stop Illicit Importation Act of 2018 - Provisions related to importation H.R. 5762: Joint Task Force to Combat Opioid Trafficking Act of 2018 - To authorize a Joint Task Force to enhance integration of the Department of Homeland Securitys border security operations to detect, interdict, disrupt, and prevent narcotics, such as fentanyl and other synthetic opioids, from entering the United States H.R. 5788: Synthetics Trafficking and Overdose Prevention Act of 2018 or STOP Act of 2018 H.R. 5803: SAFETY Act of 2018 - Provisions related to drug approval H.R. 5811: Long-Term Opioid Efficacy Act of 2018 - Postapproval study requirements H.R. 6143: Patient Right to Know Drug Prices Act - Provisions related to drug pricing H. Res. 949: Providing for consideration of the bill (H.R. 6) to provide for opioid use disorder prevention, recovery, and treatment, and for other purposes; providing for consideration of the bill (H.R. 5797) to amend title XIX of the Social Security Act to allow States to provide under Medicaid services for certain individuals with opioid use disorders in institutions for mental diseases; and providing for consideration of the bill (H.R. 6082) to amend the Public Health Service Act to protect the confidentiality of substance use disorder patient records S. 64: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation S. 92: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation S. 469: Affordable and Safe Prescription Drug Importation Act - Provisions related to importation S. 771: Improving Access to Affordable Prescription Drugs Act - Provisions related to drug pricing S. 974: CREATES Act of 2017 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems S. 1131: Fair Accountability and Innovative Research Drug Pricing Act of 2017 - Provisions related to drug pricing S. 1327: SITSA Act - Provisions related to controlled substances S. 2157: Drug-Price Transparency in Communications Act S. 2312: HELP Act - Provisions related to 340B program S. 2453: Ensuring the Value of the 340B Program Act of 2018 - Provisions to increase transparency in the 340B program S. 2553: Know the Lowest Price Act of 2018 - Provisions related to drug pricing S. 2554: Patient Right to Know Drug Prices Act - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees S. 2665: A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety S. 2680: Opioid Crisis Response Act of 2018 - Provisions related to opioids S. 3428: Lessening Addiction by Enhancing Labeling Opiods Act of 2018 S. 3519: A bill to establish a process for the Food and Drug Administration to determine whether to modify the labeling of drugs whose labeling may be outdated, including drugs with accepted uses that are not reflected in the approved labeling Drug cost and pricing policy issues Transparency policy issues Drug importation and counterfeiting policy issues Prescription drug take back and secure disposal policy issues Policy issues related to prescription drug abuse and opioids Expanded access policy issues Generic drug approval process policy issues High deductible health plans/HSA policy issues Sharing of truthful and non-misleading information about medicines with healthcare professionals and payors Risk Evaluation and Mitigation Strategy (REMS) policy issues FDA modernization policy issues PDUFA implementation policy issues 340B drug discount program policy issues Bipartisan Budget Act of 2018 (Public Law 115-123) - Part D provisions Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug compounding policy issues including federal oversight of compounded drugs Cancer drug vial size policy issues TRICARE pharmacy pilot program Drug shortages policy issues Reauthorization of the Pandemic and All-Hazards Preparedness Act Request for Information: HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs (RIN 0991-ZA49)

Client expense: $5,990,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE

H.R. 714 Use of Medicinal Marihuana H.R. 715 Rescheduling of Marihuana H.R. 975 Controlled Substances Act Application to Marihuana H.R. 1781 Synthetic Opioids H.R. 1824 Federal and State Marijuana Policy Gap Reduction S. 581 Opioids Addiction Information in Medical Records S. 780 Federal and State Marijuana Policy Gap Reduction H.R. 2020 Rescheduling of Marijuana H.R. 2063 Opioid Dispensary Registration Training Condition S. 1078 FDA Opioid Approval Procedures S. 1079 FDA Opioid Approval and Revocation S. 1327 Controlled Substance Analogues Regulation H.R. 3374 Drunk Driving H.R. 3534 State Legalized Marijuana S. 1553 Schedule 1 Controlled Substances S. 1554 Controlled Substance Continuing Education S. 1689 Controlled Substances Act H.R. 3964 Registration Requirements for Prescribers of Opioids H.R. 4482 Opioid Abuse and Addiction S. 2008 Opioid Epidemic and Drug Sample Backlogs H.R. 4903 Opioid Usage Reduction Best Practices Study H.R. 4922 Fentanyl Analogues H.R. 5109 Opioid Epidemic Distribution of Resources S. 2437 Opioid Grant Program S. 2440 Opioid Epidemic S. 2535 Opioid Quotas H.R. 5473 Alternative Methods for Data Collection H.R. 5581 Prescribers of Controlled Substances H.R. 5590 Medicare and Opioid Addictions H.R. 5723 Medicare Payment Advisory Commission H.R. 5782 Pharmaceutical Company Accountability S. 2680 Opioid Crisis S. 2691 Pharmaceutical Companies and Illegal Marketing S. 2729 Prevention of Prescription Opioid Misuse S. 2838 Reporting Information on Distribution of Opioids S. 2848 Controlled Substances and Alcohol Testing H.R. 6491 Reporting of Information on Distribution of Opioids H.R. 6608 Prescription Drug Monitoring Programs Data Collection H.R. 5812 Controlled Substance Overdose Prevention Activities

Client expense: $1,070,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)

H.R.6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Provisions relating to NIH, and drug abuse and treatment Drug abuse research and treatment related issues: H.R.1732, Synthetic Drug Control Act of 2017 H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA) H.R.3391, Medical Marijuana Research Act of 2017 S.1803, Marijuana Effective Drug Studies (MEDS) Act of 2017 S.2260, Opioids and STOP Pain Initiative Act S.2004, Combating the Opioid Epidemic Act H.R.5298, Modernizing Drug Enforcement Act of 2018 H.R.5311/S.2456, Comprehensive Addiction and Recovery Act or CARA 2.0 Act of 2018 H.R.6, SUPPORT for Patients and Communities Act S.1276, Cannabidiol Research Expansion Act Marijuana and Cannabidiol Research Expansion Act H.R.5634, Medical Cannabis Research Act of 2018

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

S. 1327, (SISTA Act) Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 H.R. 2851, (SISTA Act) Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 H.R.993, Opioid Abuse Prevention and Treatment Act of 2017 H.R. 1732, Synthetic Drug Control Act of 2017 H.R.5298, Modernizing Drug Enforcement Act of 2018

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 1917 - Sentencing Reform and Corrections Act of 2017, all provisions S. 860 - Juvenile Justice and Delinquency Prevention Reauthorization Act of 2017, all provisions H.R.1809 - Juvenile Justice Reform Act of 2017 H.R.5682 / S.2795 - FIRST STEP Act H.R.2851 / S.1327 - SITSA Act H.R.2899 - Second Chance Reauthorization Act of 2017 (and not yet reintroduced Senate companion) S.1856 / H.R.1556 - Stop Militarizing Law Enforcement Act S.827 / H.R.1906 - REDEEM Act H.R.254 - REAL Act of 2017 Package of campaign finance reforms as yet to be introduced in the House of Representatives

Client expense: $1,000,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Drug pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; CREATES Act (HR 2212/S. 974; 340B issues; SUPPORT for Patients and Communities Act (H.R. 6), Biosimilars Competition Act of 2018 (H.R. 6478), Patient Right to Know Drug Prices Act (S. 2554/H.R. 6143), Re-Valuing Anti-Microbial Products Act of 2018 (H.R. 6294), Medicare Negotiation and Competitive Licensing Act of 2018 (H.R. 6505), Making Objective Drug Evidence Revisions for New (MODERN) Labeling Act (S. 3519), citizen petitions

Client expense: Not reported · Firm income: $270,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Stop the Importation and Trafficking of Synthetic Analogues Act (S. 1327, H.R. 2851); NDAA (H.R. 5515); Immigration Policy; Mens Rea Reform Act (S. 3118); House Farm Bill (H.R. 2) - provisions re. SNAP; Community Safety and Security Act (H.R. 6691) - all provisions; Empowering Financial Institutions to Fight Human Trafficking Act (H.R. 6729); Senate Transportation and Housing (THUD) appropriations bill (S. 3023) - provision re: individuals with certain convictions and public housing benefits; Medical Cannabis Research Act of 2018 (H.R. 5634)

Client expense: $15,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2851/S. 1327, SITSA Act (new schedules and sentences for drug analogues); H.R. 6 (opioid bill); mandatory minimum sentencing reform; H.R. 3356, Prison Reform and Redemption Act (prison reform); H.R. 5682, FIRST STEP Act (prison reform); compassionate release; S. 1917, Sentencing Reform and Corrections Act (sentencing and prison reform); S. 2471, GRACE Act (compassionate release); U.S. Sentencing Commission nominations; S. 2635 (changes to fentanyl penalties); H.R. 6691 (changes to crime of violence definition); H.R. 6697/S. 3335 (changes to Armed Career Criminal Act)

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.767-Stop, Observe, Ask, and Respond (SOAR) to Health and Wellness Act of 2017 H.R.1057-Synthetics Trafficking and Overdose Prevention Act of 2017 H.R.1492-Medical Controlled Substances Transportation Act of 2017 H.R.2200-Frederick Douglass Trafficking Victims Prevention and Protection Reauthorization Act of 2017 H.R.2851-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 H.R.4922-Stopping Overdoses of Fentanyl Analogues Act S.372-Synthetics Trafficking and Overdose Prevention Act of 2017 S.256-SOAR to Health and Wellness Act of 2017 S.1327-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 S.1553-Stopping Overdoses of Fentanyl Analogues Act

Client expense: $702,392 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)

H.R.6-Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act H.R.1057-Synthetics Trafficking and Overdose Prevention Act of 2017 H.R.1492-Medical Controlled Substances Transportation Act of 2017 H.R.2851-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 H.R.3545-Overdose Prevention and Patient Safety (OPPS) Act H.R.4922-Stopping Overdoses of Fentanyl Analogues Act H.R.5176-Preventing Overdoses While in Emergency Rooms Act of 2018 H.R.5197-Alternatives to Opioids (ALTO) in the Emergency Department Act H.R.5531-Opioid Emergency Response Act H.R.5558-Alternatives to Opioids Prescribing Act H.R.6082-Overdose Prevention and Patient Safety (OPPS) Act S.372-Synthetics Trafficking and Overdose Prevention Act of 2017 S.1327-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 S.1553-Stopping Overdoses of Fentanyl Analogues Act S.2516-Alternatives to Opioids (ALTO) in the Emergency Department Act S.2609-Recovery Coaches Offer Addiction Counseling and Healing (COACH) Act S.2610-Preventing Overdoses While in Emergency Departments Act of 2018

Client expense: $702,392 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)

H.R. 6: SUPPORT for Patients and Communities Act - To provide for opioid use disorder prevention, recovery, and treatment, and for other purposes H.R. 449: Synthetic Drug Awareness Act: Provisions related to synthetic drug report H.R. 878: Right to Try Act of 2017 - Provisions related to use of unapproved medical products by patients with a terminal illness H.R. 1245: Affordable and Safe Prescription Drug Importation Act - Provisions related to importation H.R. 1480: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation H.R. 2212: CREATES Act of 2017 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 2851: Stop Importation and Trafficking of Synthetic Analogues (SITSA) Act - Provisions related to controlled substances H.R. 4710: 340B Protecting Access for the Underserved and Safety-net Entities Act or PAUSE Act - Provisions related to the 340B program HR 4993 Vaccine Access Improvement Act HR 4297/S 2103 Protecting Seniors Through Immunization Act H.R. 5311: CARA 2.0 Act of 2018 - Provisions to reauthorize and expand the Comprehensive Addiction and Recovery Act H.R. 5598: 340B Optimization Act - Provisions related to transparency in the 340B program H.R. 5687: SOUND Disposal and Packaging Act - To require improved packaging and disposal methods with respect to certain drugs H.R. 6142: Reducing Drug Waste Act of 2018 - Action plan and report on vial size waste HR 6378/S 2852 Pandemic and All Hazards Preparedness Act reauthorization HR 6294 REVAMP Act S. 64: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation S. 92: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation S. 469: Affordable and Safe Prescription Drug Importation Act - Provisions related to importation S. 974: CREATES Act of 2017 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems S. 1327: SITSA Act - Provisions related to controlled substances S. 2312: HELP Act - Provisions related to 340B program S. 2453: Ensuring the Value of the 340B Program Act of 2018 - Provisions to increase transparency in the 340B program Drug cost and pricing policy issues Transparency policy issues Drug importation and counterfeiting policy issues Prescription drug take back and secure disposal policy issues Risk Evaluation and Mitigation Strategy (REMS) policy issues FDA modernization policy issues 340B drug discount program policy issues 21st Century Cures Act (Public Law 114-255) - Provisions related to biopharmaceutical discovery, development, delivery, and transparency Senate HELP Committee Innovation Agenda - Provisions related to biopharmaceutical discovery and development of FDA policy TRICARE pharmacy pilot program Reauthorization of the Pandemic and All-Hazards Preparedness Act Request for Information: HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs (RIN 0991-ZA49) Pandemic and All-Hazards Preparedness Act, provisions related to emerging infectious diseases and antimicrobial resistance. HR 6 - SUPPORT for Patients and Communities Act HR 5687 - SOUND Disposal and Packaging ActHR 5333 - Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018 S 2315 - Over-the-Counter Drug Safety, Innovation, and Reform ActHR 394/S 85 - Restoring Access to Medication Act of 2017 HR 6199 - To amend the Internal Revenue Code of 1986 to include certain over-the-counter medical products as qualified medical expenses. HR 6157 - FY19 Defense Appropriations ActS 3159 - FY19 Defense Appropriations ActS 3158 - FY19 Labor-HHS-Education Appropriations ActHouse Draft - FY19 Labor-HHS-Education Appropriations ActPatient Access in Medicaid program340B Discount Drug ProgramHR 4710 - 340B PAUSE ActHR 5598 - 340B Optimization Act HR 5958 - Phair Pricing Act of 2018

Client expense: $1,400,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE

H.R. 2851 and S. 1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 Public Law No: 114-145, Ensuring Patient Access and Effective Drug Enforcement Act of 2016

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)

Client expense: Not reported · Firm income: $290,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 714 Use of Medicinal Marihuana H.R. 715 Rescheduling of Marihuana H.R. 975 Controlled Substances Act Application to Marihuana H.R. 1781 Synthetic Opioids H.R. 1824 Federal and State Marijuana Policy Gap Reduction S. 581 Opioids Addiction Information in Medical Records S. 780 Federal and State Marijuana Policy Gap Reduction H.R. 2020 Rescheduling of Marijuana H.R. 2063 Opioid Dispensary Registration Training Condition S. 1078 FDA Opioid Approval Procedures S. 1079 FDA Opioid Approval and Revocation S. 1327 Controlled Substance Analogues Regulation H.R. 3374 Drunk Driving H.R. 3534 State Legalized Marijuana S. 1553 Schedule 1 Controlled Substances S. 1554 Controlled Substance Continuing Education S. 1689 Controlled Substances Act H.R. 3964 Registration Requirements for Prescribers of Opioids H.R. 4482 Opioid Abuse and Addiction S. 2008 Opioid Epidemic and Drug Sample Backlogs H.R. 4903 Opioid Usage Reduction Best Practices Study H.R. 4922 Fentanyl Analogues H.R. 5109 Opioid Epidemic Distribution of Resources S. 2437 Opioid Grant Program S. 2440 Opioid Epidemic S. 2535 Opioid Quotas **Issues lobbied without specific bill number: Workers' Compensation Medicare Set-Aside H.R. 5473 Alternative Methods for Data Collection H.R. 5581 Prescribers of Controlled Substances H.R. 5590 Medicare and Opioid Addictions H.R. 5723 Medicare Payment Advisory Commission H.R. 5782 Pharmaceutical Company Accountability S. 2680 Opioid Crisis S. 2691 Pharmaceutical Companies and Illegal Marketing S. 2729 Prevention of Prescription Opioid Misuse S. 2838 Reporting Information on Distribution of Opioids S. 2848 Controlled Substances and Alcohol Testing

Client expense: $1,590,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)

H.R. 6: SUPPORT for Patients and Communities Act - To provide for opioid use disorder prevention, recovery, and treatment, and for other purposes H.R. 449: Synthetic Drug Awareness Act: Provisions related to synthetic drug report H.R. 749: Lower Drug Costs through Competition Act - Provisions related to generic drug approvals H.R. 878: Right to Try Act of 2017 - Provisions related to use of unapproved medical products by patients with a terminal illness H.R. 1245: Affordable and Safe Prescription Drug Importation Act - Provisions related to importation H.R. 1480: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation H.R. 1628: American Health Care Act of 2017 - Provisions related to the biopharmaceutical industry including repeal of brand pharmaceutical manufacturer fee and individual and employer mandates, insurance affordability provisions, and Medicaid reforms H.R. 1776: Improving Access to Affordable Prescription Drugs Act - Provisions related to drug pricing H.R. 2025: Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 - Provisions related to labeling information describing abuse-deterrent properties H.R. 2026: Pharmaceutical Information Exchange Act - Provisions related to economic and scientific information communications H.R. 2051: FAST Generics Act of 2017 - Provisions related to REMS and limited distribution systems H.R. 2063: Opioid Preventing Abuse through Continuing Education (PACE) Act of 2017 - Provisions related to prescriber training H.R. 2212: CREATES Act of 2017 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 2851: Stop Importation and Trafficking of Synthetic Analogues (SITSA) Act - Provisions related to controlled substances H.R. 3528: Every Prescription Conveyed Securely Act - e-Prescribing for coverage under part D of the Medicare program of prescription drugs that are controlled substances H.R. 3545: Overdose Prevention and Patient Safety Act - Provisions related to substance use disorder information sharing H.R. 3692: Addiction Treatment Access Improvement Act of 2017 - Provisions related to medication assisted treatment (MAT) access H.R. 4275: Empowering Pharmacists in the Fight Against Opioid Abuse Act - Provisions related to pharmacist education H.R. 4284: Indexing Narcotics, Fentanyl, and Opioids (INFO) Act of 2017 - Provisions related to substance data collection H.R. 4710: 340B Protecting Access for the Underserved and Safety-net Entities Act or PAUSE Act - Provisions related to the 340B program H.R. 4482: Opioid Abuse Deterrence, Research, and Recovery Act of 2017 - Provisions related to prescriber requirements H.R. 5002: Advancing Cutting Edge Research Act - Provisions related to non-addiction pain medication H.R. 5009: Jessies Law - Provisions related to patient information sharing H.R. 5041: The Safe Disposal of Unused Medication Act - Provisions related to drug disposal H.R. 5102: Substance Use Disorder Workforce Loan Repayment Act of 2018 - Provisions related to student loan repayment to substance use disorder (SUD) providers H.R. 5150: Protecting Medicare from Excessive Price Increases Act of 2018 - To require drug manufacturers to pay a Medicare part B rebate for certain drugs H.R. 5151: To amend the Public Health Service Act to reauthorize a grant program improving treatment for pregnant and postpartum women H.R. 5202: Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 - Provisions related to drug delivery H.R. 5228: SCREEN Act - Provisions related to drug recall authority H.R. 5247: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 - Provisions related to use of unapproved medical products by patients with a terminal illness H.R. 5261: Treatment, Education, and Community Help to Combat Addiction Act of 2018 - Provisions related to grants for substance use disorder (SUD) prevention, treatment, and recovery H.R. 5311: CARA 2.0 Act of 2018 - Provisions to reauthorize and expand the Comprehensive Addiction and Recovery Act H.R. 5327: Comprehensive Opioid Recovery Centers Act of 2018 - Provisions related to opioid recovery center grants H.R. 5329: Poison Center Network Enhancement Act of 2018 - Provisions related to national poison center funding and other prevention funding H.R. 5353: Eliminating Opioid Related Infectious Diseases Act of 2018 - Provisions related to CDC infection surveillance and other funding H.R. 5477: Rural DOCS Act - To provide for a demonstration project to increase substance use provider capacity under the Medicaid program H.R. 5580: STOP Fentanyl Deaths Act of 2018 - To authorize the Secretary of Health and Human Services to conduct programs to address the usage of illicit drugs, particularly fentanyl H.R. 5598: 340B Optimization Act - Provisions related to transparency in the 340B program H.R. 5676: Stop Excessive Narcotics in our Retirement Communities Protection Act of 2018 - To authorize the suspension of payments by Medicare prescription drug plans and MA-PD plans pending investigations of credible allegations of fraud by pharmacies H.R. 5687: SOUND Disposal and Packaging Act - Provisions related to packaging and disposal methods with respect to certain drugs H.R. 5711: Improving Access to Mental Health Services Act - To allow National Health Service Corps members to provide obligated service as behavioral and mental health professionals at schools, other community-based settings, or patient homes H.R. 5723: Expanding Oversight of Opioid Prescribing and Payment Act of 2018 - To require the Medicare Payment Advisory Commission to report on opioid payment, adverse incentives, and data under the Medicare program H.R. 5752: Stop Illicit Importation Act of 2018 - Provisions related to importation H.R. 5762: Joint Task Force to Combat Opioid Trafficking Act of 2018 - To authorize a Joint Task Force to enhance integration of the Department of Homeland Securitys border security operations to detect, interdict, disrupt, and prevent narcotics, such as fentanyl and other synthetic opioids, from entering the United States H.R. 5774: Combating Opioid Abuse for Care in Hospitals Act of 2018 - Provisions related to opioids H.R. 5775: Providing Reliable Options for Patients and Educational Resources Act of 2018 - To require Medicare Advantage plans and part D prescription drug plans to include information on the risks associated with opioids, coverage of certain nonopioid treatments used to treat pain, and on the safe disposal of prescription drugs H.R. 5796: Responsible Education Achieves Care and Healthy Outcomes for Users' Treatment (REACH OUT) Act of 2018 - To require the Secretary of Health and Human Services to provide grants for eligible entities to provide technical assistance to outlier prescribers of opioids H.R. 5803: SAFETY Act of 2018 - Provisions related to drug approval H.R. 5811: Long-Term Opioid Efficacy Act of 2018 - Postapproval study requirements H.R. 6071: SERV Communities Act - Provisions related to transparency in the 340B program H.R. 6110: Dr. Todd Graham Pain Management, Treatment, and Recovery Act of 2018' H.R. 6142: Reducing Drug Waste Act of 2018 - Action plan and report on vial size waste S. 204: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 - Provisions related to use of unapproved medical products by patients with a terminal illness S. 64: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation S. 92: Safe and Affordable Drugs from Canada Act of 2017 - Provisions related to importation S. 469: Affordable and Safe Prescription Drug Importation Act - Provisions related to importation S. 771: Improving Access to Affordable Prescription Drugs Act - Provisions related to drug pricing S. 974: CREATES Act of 2017 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems S. 1131: Fair Accountability and Innovative Research Drug Pricing Act of 2017 - Provisions related to drug pricing S. 1327: SITSA Act - Provisions related to controlled substances S. 2312: HELP Act - Provisions related to 340B program S. 2406: ACE Research Act - Research initiatives of the NIH S. 2453: Ensuring the Value of the 340B Program Act of 2018 - Provisions to increase transparency in the 340B program S. 2553: Know the Lowest Price Act of 2018 - Provisions related to drug pricing S. 2554: Patient Right to Know Drug Prices Act - Provisions related to drug pricing S. 2589: Comprehensive Opioid Recovery Centers Act of 2018 - Provisions related to CDC infection surveillance and other funding S. 2665: A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety S. 2680: Opioid Crisis Response Act of 2018 - Provisions related to opioids S. 2842: Opioid Addiction Recovery Fraud Prevention Act of 2018 - Provisions related to opioid treatment programs or products S. __: Drug Accepted Use Labeling Act of 2018 - Provisions related to labeling Drug cost and pricing policy issues Transparency policy issues Drug importation and counterfeiting policy issues Prescription drug take back and secure disposal policy issues Policy issues related to prescription drug abuse and opioids Expanded access policy issues Generic drug approval process policy issues Sharing of truthful and non-misleading information about medicines with healthcare professionals and payors Risk Evaluation and Mitigation Strategy (REMS) policy issues Limited distribution systems in the pharmaceutical supply chain policy issues FDA modernization policy issues 340B drug discount program policy issues 21st Century Cures Act (Public Law 114-255) - Provisions related to biopharmaceutical discovery, development, delivery, and transparency Senate HELP Committee Innovation Agenda - Provisions related to biopharmaceutical discovery and development of FDA policy Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug compounding policy issues including federal oversight of compounded drugs Cancer drug vial size policy issues TRICARE pharmacy pilot program Opioids shortages policy issues Reauthorization of the Pandemic and All-Hazards Preparedness Act Request for Information: HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs (RIN 0991-ZA49)

Client expense: $5,540,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institute of Standards & Technology (NIST), Office of Management & Budget (OMB), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)

S. 1327, (SISTA Act) Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 H.R. 2851, (SISTA Act) Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 H.R.993, Opioid Abuse Prevention and Treatment Act of 2017

Client expense: $100,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.3356 - Prison Reform and Redemption Act H.R.5682 - FIRST STEP Act S.2795 - FIRST STEP Act H.R.2851 - SITSA Act S.1327 - SITSA Act H.R.2899 - Second Chance Reauthorization Act of 2017 (and not yet reintroduced Senate companion) S.1856 - Stop Militarizing Law Enforcement Act H.R.1556 - Stop Militarizing Law Enforcement Act S.827 - REDEEM Act H.R.1906 - REDEEM Act Package of campaign finance reforms as yet to be introduced in the House of Representatives S. 860, Juvenile Justice and Delinquency Prevention Reauthorization Act of 2017, all provisions H.R.1809 - Juvenile Justice Reform Act of 2017 H.R. 3713 - Sentencing Reform Act of 2015, all provisions (114th Congress) S. 1917 - Sentencing Reform and Corrections Act of 2017, all provisions

Client expense: $1,000,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2019, provisions relating to NIH and drug abuse and treatment Drug abuse research and treatment related issues: H.R.1732, Synthetic Drug Control Act of 2017 H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA) H.R.3391, Medical Marijuana Research Act of 2017 S.1803, Marijuana Effective Drug Studies (MEDS) Act of 2017 S.2260, Opioids and STOP Pain Initiative Act S.2004, Combating the Opioid Epidemic Act H.R.5298, Modernizing Drug Enforcement Act of 2018 H.R.5311/S.2456, Comprehensive Addiction and Recovery Act or CARA 2.0 Act of 2018 H.R.6, SUPPORT for Patients and Communities Act S.1276, Cannabidiol Research Expansion Act Marijuana and Cannabidiol Research Expansion Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R. 2851/S. 1327, SITSA Act (new schedules and sentences for drug analogues); mandatory minimum sentencing reform; H.R. 3356, Prison Reform and Redemption Act (prison reform); H.R. 5682, FIRST STEP Act (prison reform); oversight of Bureau of Prisons; halfway houses; compassionate release; S. 1917, Sentencing Reform and Corrections Act (sentencing and prison reform); S. 1994, CORRECTIONS Act (prison reform); S. 2471, GRACE Act (compassionate release); U.S. Sentencing Commission nominations; S. 2635 (changes to fentanyl penalties)

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE

H.R. 2851/S. 1327, SITSA Act (new schedules and sentences for drug analogues); mandatory minimum sentencing reform; H.R. 3356, Prison Reform and Redemption Act (prison reform); H.R. 5682, FIRST STEP Act (prison reform); oversight of Bureau of Prisons; halfway houses; compassionate release; S. 1917, Sentencing Reform and Corrections Act (sentencing and prison reform); S. 1994, CORRECTIONS Act (prison reform); S. 2471, GRACE Act (compassionate release); U.S. Sentencing Commission nominations; S. 2635 (changes to fentanyl penalties)

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE

H.R. 62, the Gun Violence Reduction Resources Act, would authorize the hiring of an additional 200 agents and investigators for the Bureau of Alcohol, Tobacco, Firearms and Explosives in the U.S. Department of Justice; H.R. 115/S. 1085, the Thin Blue Line Act, would increase the penalty for offenders who kill or attempt to kill law enforcement or other public safety officers; H.R. 426/S. 1087, the Protecting Lives Using Surplus (PLUS) Equipment Act, which would restore all Federal equipment assistance programs to State and local law enforcement which were restricted by Executive Order 13688; H.R. 613/S. 1084, the Lieutenant Osvaldo Albarati Correctional Officer Self-Protection Act, would direct the Bureau of Prisons to make secure firearms storage areas accessible to employees at all of its facilities; H.R. 622, the Local Law Enforcement for Local Lands Act, would terminate the law enforcement functions of the U.S. Forest Service and the Bureau of Land Management; H.R. 664, the Stem the Tide of Overdose Prevalence from Opiate Drugs (STOP OD) Act, would aim to reduce the curb the number of overdoses due to synthetic fentanyl and helps equip law enforcement officers with naloxone; H.R. 695/S. 705, the Child Protection Improvements Act, which would allow organizations that serve children and the elderly to use the FBI database to conduct background checks on potential employees; H.R. 909/S. 322, the Pet and Women Safety (PAWS) Act, would expand existing Federal protections to the pets of domestic abuse victims and establish a grant program to assist victims and their pets when they leave their abusers; H.R. 1039/S. 367, the Probation Officer Protection Act, which would amend section 3606 of Title 18, United States Code, to grant probation officers authority to arrest hostile third parties who obstruct or impede a probation officer in the performance of official duties; H.R. 1057/S. 372, the Synthetics Trafficking and Overdose Prevention (STOP) Act would close the loophole and allow U.S Border and Customs Protections to effectively enforce customs laws that will stop the flow of deadly synthetic drugs into our communities from China; H.R. 1494/S. 654, the Animal Cruelty and Torture Act which would provide criminal penalty for those who engage in animal crushing, as well as for those who create or distribute such films; H.R. 1498, the End Racial Profiling Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search-absent an eyewitness description-and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; H.R. 1636, the School Safety Act, which would reauthorize and expand the Secure Our Schools program administered by the Office of Community Oriented Policing Services (COPS); H.R. 1732, the Synthetic Drug Control Act, which would enhance the ability of law enforcement to combat synthesized drugs by amending the Controlled Substances Act to clarify how controlled substance analogues are to be regulated; H.R. 1761, the Protection Against Child Exploitation Act, which would close an existing loophole in current statute by clarifying certain definitions in child pornography law; H.R. 1865/S. 1693, the Allow States and Victims to Fight Online Sex Trafficking Act, which would to update and clarify Section 230 of the Communications Decency Act to ensure that charges can be brought against interactive computer service providers who engage in criminal behavior or with reckless disregard to criminal activity; H.R. 1886/S. 573, the National Criminal Justice Commission Act, which would establish National Criminal Justice Commission to study the nations criminal justice systems; H.R. 1979, the No More Tulias: Drug Law Enforcement Evidentiary Standards Improvement Act, which would significantly limit States who fund anti-drug task forces from receiving Federal funding from the Edward J. Byrne Memorial Justice Assistant Grants program; H.R. 2213, the Anti-Bordering Corruption Reauthorization Act, which would improve the ability of the U.S. Customs and Border Patrol to hire new officers; H.R. 2437/S. 1134, the Back the Blue Act, which contains a number of amendments to Federal law expanding the death penalty for persons who kill law enforcement officers, restrictions on habeas corpus, limitation on recovery of damages incurred during an arrest as well as two amendments to the Law Enforcement Officers Safety Act (LEOSA) with respect to magazine capacity and the Guns Free School Zones Act; H.R. 2513, the Police Officers Protecting Children Act, which would add qualified active and retired law enforcement officers, as defined by the Law Enforcement Officers Safety Act (LEOSA), to the list of exemptions to the Guns Free School Zones Act; H.R. 2561, the Protecting Police Officers of the Law in Civilian Establishments Act, which would clarify that existing Federal laws which prohibit the carriage of firearms onto Federal property like post offices, Social Security offices and Veterans Affairs offices do not apply to law enforcement officers in uniform; H.R. 2851/S. 1327, the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act, would amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated by allowing the Attorney General to add synthetic analogues either temporarily/permanently to Schedule A; H.R. 3003, Section 2, the "No Sanctuary for Criminals Act, which would penalize law enforcement agencies by withholding Federal fudning from so-called sanctuary cities; H.R. 3089/S. 1454, the Corporate Transparency Act, would require the Federal government to collect beneficial ownership information for corporations and limited liability companies unless the State already collects this information; H.R. 3249, the Project Safe Neighborhoods Grant Program Authorization Act, would reauthorize and fully fund the Project Safe Neighborhoods program; H.R. 3790/S. 1854, the Federal Firearms Licensee Protection Act, which would increase penalties on those who burglarize or rob a Federal Firearms Licensee; H.R. 4471/S. 2492, the NICS Denial Notification Act, would require the U.S. Department of Justice to notify State and local law enforcement agencies if a prohibited person attempts to purchase a firearm in their jurisdiction; H.R. 4477/S. 2135, the "Fix NICS Act, would require all Federal agencies and States to produce NICS implementation plans focused on uploading accurate, required information to the background check system; H.R. 4768/S. 2715, the National Strategy for Combating the Financing of Transnational Criminal Organizations Act, which would codify an existing Executive Order and direct the Federal government to develop a national strategy to combat transnational criminal organizations; H.R. 4854/S. 2345, the Justice Served Act, which will increase the capacity of prosecutors to address the backlog of violent crime cases involving suspects identified through DNA evidence; H.R. 5060, the Heroes Lesley Zerebney and Gilbert Vega First Responders Survivors Support Act, which would increase the amount of the death benefit provide by the Public Safety Officers benefits (PSOB) program as well as other benefits administered by the PSOB; H.R. 5219, the Opioid Prescription Verification Act, which would require retail sellers of opioids to verify the identity of the purchaser; H.R. 5682 (as introduced), the Formerly Incarcerated Reenter Society Transformed Safely Transitioning Every Person (FIRST STEP) Act, which may result in the premature release of thousands of convicted offenders; H.R. 5698/S. 2794, the Protect and Serve Act, which would make it a Federal crime to target a law enforcement with an assault that results in seriously bodily harm or death; H.R. 5788, the Securing the International Mail Against Opioids Act, which would close the loophole and allow U.S Custom and Border Protection to effectively enforce customs laws that will stop the flow of deadly synthetic drugs into our communities from China; H.R. 5871/S. 2763, the "Providing Officers with Electronic Resources (POWER) Act, which would establishes a grant program to be administered by the Office of Community Oriented Policing Services (COPS) in order to provide State and local law enforcement agencies with portable chemical screening devices to detect dangerous synthetic opioids and other drugs; S. 207, the Synthetic Abuse and Labeling of Toxic Substances (SALTS) Act, would close the existing loophole for the manufacturers on analogue drug sales and distribution; S. 318, the COPS Improvement Act, would reauthorize the Office of Community Oriented Policing Services (COPS) and improve its existing hiring program; S. 446, the Constitutional Concealed Carry Reciprocity Act, which would allow any civilian concealed carry permit holder to travel to any other State issuing concealed carry permits without any training or safety requirements; S. 739, the Protecting Kids from Candy-Flavored Drugs Act, would impose increased prison sentences on adults who manufacture, create, distribute, or possess with the intent to distribute a controlled substance that is appealing to kids, whether designed or flavored; S. 748, the Protecting the Rights of Families and Immigrants Who Legally Entered From Detention (PROFILED) Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search, absent an eyewitness description, and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; S. 1241, the Combating Money Laundering, Terrorist Financing, and Counterfeiting Act, which would update and strengthen Federal laws to combat money laundering and provide law enforcement with additional tools to restrict the ability of criminals to profit from their crimes; S. 1311, the Abolish Human Trafficking Act, reauthorizes parts of the Trafficking Victims Protection Act and expand the authority of State and local agencies to obtain wiretap warrants for trafficking investigations; S. 1312, the Trafficking Victims Protection Act, would help prevent human trafficking by promoting training for law enforcement and school resource officers through the Office of Community Oriented Policing Services (COPS) to better identify and respond to human trafficking victims; S. 1327, the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act, would amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated by allowing the Attorney General to add synthetic analogues either temporarily/permanently to Schedule A; S. 1666, the "Helping Overcome Trauma for Children Alone in Rear Seats (HOTCARS) Act, which would direct the U.S. Department of transportation to implement a rule requiring vehicles to notify drivers if a child or other passenger has been inadvertently left behind; S. 1781, the National White Collar Crime Control Act, which would reauthorize grant programs to law enforcement to combat white collar crimes; S. 2389, Erics Law, which would amend current law to allow Federal prosecutors to impanel a second jury for the sentencing phase of capital cases; S. 2715, the Criminal Organizations Narcotics, Finance, Resources, Operations and Network Targeting (CONFRONT) Act, which would codify an existing Executive Order and direct the Federal government to develop a national strategy to combat transnational criminal organizations; S. 2759, the EAGLES Act, which would reauthorize the National Threat Asessment Center (NTAC) within the U.S. Department of Homeland Security; S. 2774, which would reauthorize the Office of Community Oriented Policing Services (COPS) within the U.S. Department of Justice through 2023; S. 2789, the "Substance Abuse Prevention Act, which would reauthorize the Office of National Drug Control Policy and the programs it administers; S. 2973, the Kelsey Smith Act, which would require telephone companies and wireless carriers to disclose cell-site location data without a warrant in certain exigent circumstances; Legislation which would protect the personal information of law enforcement officers and their families from public access; Legislation or amendments that would have the effect of weakening PL 106-185, the Civil Asset Forfeiture Reform Act of 2000; Legislation which would create or fund civilian review boards of law enforcement at any level of government; and Legislation which would further normalize relations with Cuba until that nation ceases to be a safe harbor for cop-killers and other fugitives.

Client expense: $55,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, White House Office

Stop the Importation and Trafficking of Synthetic Analogues Act (S. 1327, H.R. 2851); Ending the Fentanyl Crisis Act (S.2635); Building America's Trust Act (S. 1757); Securing America's Future Act (H.R. 4760); NDAA (H.R. 5515); Immigration Policy; Mens Rea Reform Act (S. 3118); House Farm Bill (H.R. 2) - provisions re. SNAP; Protect and Serve Act (H.R. 5693, S. 2794)

Client expense: $15,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.1057-Synthetics Trafficking and Overdose Prevention Act of 2017 H.R.1492-Medical Controlled Substances Transportation Act of 2017 H.R.2851-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 H.R.3545-Overdose Prevention and Patient Safety (OPPS) Act H.R.5176-Preventing Overdoses While in Emergency Rooms Act of 2018 H.R.5197-Alternatives to Opioids (ALTO) in the Emergency Department Act S.372-Synthetics Trafficking and Overdose Prevention Act of 2017 S.1327-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 S.2516-Alternatives to Opioids (ALTO) in the Emergency Department Act S.2609-Recovery Coaches Offer Addiction Counseling and Healing (COACH) Act S.2610-Preventing Overdoses While in Emergency Departments Act of 2018

Client expense: $520,414 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

H.R.767-Stop, Observe, Ask, and Respond (SOAR) to Health and Wellness Act of 2017 H.R.1057-Synthetics Trafficking and Overdose Prevention Act of 2017 H.R.2200-Frederick Douglass Trafficking Victims Prevention and Protection Reauthorization Act of 2017 H.R.2851-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 S.372-Synthetics Trafficking and Overdose Prevention Act of 2017 S.256-SOAR to Health and Wellness Act of 2017 S.1327-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017

Client expense: $520,414 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

H.R. 62, the Gun Violence Reduction Resources Act, would authorize the hiring of an additional 200 agents and investigators for the Bureau of Alcohol, Tobacco, Firearms and Explosives in the U.S. Department of Justice; H.R. 115/S. 1085, the Thin Blue Line Act, would increase the penalty for offenders who kill or attempt to kill law enforcement or other public safety officers; H.R. 426/S. 1087, the Protecting Lives Using Surplus (PLUS) Equipment Act, which would restore all Federal equipment assistance programs to State and local law enforcement which were restricted by Executive Order 13688; H.R. 613/S. 1084, the Lieutenant Osvaldo Albarati Correctional Officer Self-Protection Act, would direct the Bureau of Prisons to make secure firearms storage areas accessible to employees at all of its facilities; H.R. 622, the Local Law Enforcement for Local Lands Act, would terminate the law enforcement functions of the U.S. Forest Service and the Bureau of Land Management; H.R. 664, the Stem the Tide of Overdose Prevalence from Opiate Drugs (STOP OD) Act, would aim to reduce the curb the number of overdoses due to synthetic fentanyl and helps equip law enforcement officers with naloxone; H.R. 695/S. 705, the Child Protection Improvements Act, which would allow organizations that serve children and the elderly to use the FBI database to conduct background checks on potential employees; H.R. 909/S. 322, the Pet and Women Safety (PAWS) Act, would expand existing Federal protections to the pets of domestic abuse victims and establish a grant program to assist victims and their pets when they leave their abusers; H.R. 1039/S. 367, the Probation Officer Protection Act, which would amend section 3606 of Title 18, United States Code, to grant probation officers authority to arrest hostile third parties who obstruct or impede a probation officer in the performance of official duties; H.R. 1057/S. 372, the Synthetics Trafficking and Overdose Prevention (STOP) Act would close the loophole and allow U.S Border and Customs Protections to effectively enforce customs laws that will stop the flow of deadly synthetic drugs into our communities from China; H.R. 1494/S. 654, the Animal Cruelty and Torture Act which would provide criminal penalty for those who engage in animal crushing, as well as for those who create or distribute such films; H.R. 1498, the End Racial Profiling Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search-absent an eyewitness description-and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; H.R. 1636, the School Safety Act, which would reauthorize and expand the Secure Our Schools program administered by the Office of Community Oriented Policing Services (COPS); H.R. 1732, the Synthetic Drug Control Act, which would enhance the ability of law enforcement to combat synthesized drugs by amending the Controlled Substances Act to clarify how controlled substance analogues are to be regulated; H.R. 1761, the Protection Against Child Exploitation Act, which would close an existing loophole in current statute by clarifying certain definitions in child pornography law; H.R. 1865/S. 1693, the Allow States and Victims to Fight Online Sex Trafficking Act, which would to update and clarify Section 230 of the Communications Decency Act to ensure that charges can be brought against interactive computer service providers who engage in criminal behavior or with reckless disregard to criminal activity; H.R. 1886/S. 573, the National Criminal Justice Commission Act, which would establish National Criminal Justice Commission to study the nations criminal justice systems; H.R. 1892/S. 1108, the Honoring Hometown Heroes Act, which would amend existing U.S. flag Code to allow governors to fly the American flag at half-staff in the event a law enforcement or other public safety officers falls in the line of duty; H.R. 1979, the No More Tulias: Drug Law Enforcement Evidentiary Standards Improvement Act, which would significantly limit States who fund anti-drug task forces from receiving Federal funding from the Edward J. Byrne Memorial Justice Assistant Grants program; H.R. 2142/S. 708, the International Narcotics Trafficking Emergency Response by Detecting Incoming Contraband with Technology (INTERDICT) Act would ensure that U.S. Customs and Border Protections (CBP) will have additional portable chemical screening devices at ports of entry, mail and express consignment facilities, and more resources at the CBP labs; H.R. 2213, the Anti-Bordering Corruption Reauthorization Act, which would improve the ability of the U.S. Customs and Border Patrol to hire new officers; H.R. 2437/S. 1134, the Back the Blue Act, which contains a number of amendments to Federal law expanding the death penalty for persons who kill law enforcement officers, restrictions on habeas corpus, limitation on recovery of damages incurred during an arrest as well as two amendments to the Law Enforcement Officers Safety Act (LEOSA) with respect to magazine capacity and the Guns Free School Zones Act; H.R. 2513, the Police Officers Protecting Children Act, which would add qualified active and retired law enforcement officers, as defined by the Law Enforcement Officers Safety Act (LEOSA), to the list of exemptions to the Guns Free School Zones Act; H.R. 2561, the Protecting Police Officers of the Law in Civilian Establishments Act, which would clarify that existing Federal laws which prohibit the carriage of firearms onto Federal property like post offices, Social Security offices and Veterans Affairs offices do not apply to law enforcement officers in uniform; H.R. 2851/S. 1327, the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act, would amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated by allowing the Attorney General to add synthetic analogues either temporarily/permanently to Schedule A; H.R. 3003, Section 2, the "No Sanctuary for Criminals Act, which would penalize law enforcement agencies by withholding Federal fudning from so-called sanctuary cities; H.R. 3089/S. 1454, the Corporate Transparency Act, would require the Federal government to collect beneficial ownership information for corporations and limited liability companies unless the State already collects this information; H.R. 3249, the Project Safe Neighborhoods Grant Program Authorization Act, would reauthorize and fully fund the Project Safe Neighborhoods program; H.R. 3790/S. 1854, the Federal Firearms Licensee Protection Act, which would increase penalties on those who burglarize or rob a Federal Firearms Licensee; H.R. 4471/S. 2492, the NICS Denial Notification Act, would require the U.S. Department of Justice to notify State and local law enforcement agencies if a prohibited person attempts to purchase a firearm in their jurisdiction; H.R. 4477/S. 2135, the "Fix NICS Act, would require all Federal agencies and States to produce NICS implementation plans focused on uploading accurate, required information to the background check system; H.R. 4768/S. 2715, the National Strategy for Combating the Financing of Transnational Criminal Organizations Act, which would codify an existing Executive Order and direct the Federal government to develop a national strategy to combat transnational criminal organizations; H.R. 4854/S. 2345, the Justice Served Act, which will increase the capacity of prosecutors to address the backlog of violent crime cases involving suspects identified through DNA evidence; H.R. 5060, the Heroes Lesley Zerebney and Gilbert Vega First Responders Survivors Support Act, which would increase the amount of the death benefit provide by the Public Safety Officers benefits (PSOB) program as well as other benefits administered by the PSOB; S. 207, the Synthetic Abuse and Labeling of Toxic Substances (SALTS) Act, would close the existing loophole for the manufacturers on analogue drug sales and distribution; S. 318, the COPS Improvement Act, would reauthorize the Office of Community Oriented Policing Services (COPS) and improve its existing hiring program; S. 446, the Constitutional Concealed Carry Reciprocity Act, which would allow any civilian concealed carry permit holder to travel to any other State issuing concealed carry permits without any training or safety requirements; S. 739, the Protecting Kids from Candy- Flavored Drugs Act, would impose increased prison sentences on adults who manufacture, create, distribute, or possess with the intent to distribute a controlled substance that is appealing to kids, whether designed or flavored; S. 748 (Menendez, D-NJ), the Protecting the Rights of Families and Immigrants Who Legally Entered From Detention (PROFILED) Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search, absent an eyewitness description, and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; S. 1241, the Combating Money Laundering, Terrorist Financing, and Counterfeiting Act, which would update and strengthen Federal laws to combat money laundering and provide law enforcement with additional tools to restrict the ability of criminals to profit from their crimes; S. 1311, the Abolish Human Trafficking Act, reauthorizes parts of the Trafficking Victims Protection Act and expand the authority of State and local agencies to obtain wiretap warrants for trafficking investigations; S. 1312, the Trafficking Victims Protection Act, would help prevent human trafficking by promoting training for law enforcement and school resource officers through the Office of Community Oriented Policing Services (COPS) to better identify and respond to human trafficking victims; S. 1666, the Helping Overcome Trauma for Children Alone in Rear Seats (HOTCARS) Act, which would direct the U.S. Department of transportation to implement a rule requiring vehicles to notify drivers if a child or other passenger has been inadvertently left behind; S. 1781, the National White Collar Crime Control Act, which would reauthorize grant programs to law enforcement to combat white collar crimes; S. 2389, Erics Law, which would amend current law to allow Federal prosecutors to impanel a second jury for the sentencing phase of capital cases; S. 2495, the Students, Teachers, and Officers Preventing (STOP) School Violence Act, which would reauthorize and expand the existing Securie Our Schools program administered by the Office of Community Oriented Policing Services (COPS); S. 2763, the "Providing Officers with Electronic Resources (POWER) Act, which would establishes a grant program to be administered by the Office of Community Oriented Policing Services (COPS) in order to provide State and local law enforcement agencies with portable chemical screening devices to detect dangerous synthetic opioids and other drugs; Legislation which would protect the personal information of law enforcement officers and their families from public access; Legislation or amendments that would have the effect of weakening PL 106-185, the Civil Asset Forfeiture Reform Act of 2000; Legislation which would create or fund civilian review boards of law enforcement at any level of government; and Legislation which would further normalize relations with Cuba until that nation ceases to be a safe harbor for cop-killers and other fugitives.

Client expense: $55,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, White House Office

H.R. 2851 and S. 1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 Public Law No: 114-145, Ensuring Patient Access and Effective Drug Enforcement Act of 2016

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 1327, (SISTA Act) Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 H.R. 2851, (SISTA Act) Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 H.R.993, Opioid Abuse Prevention and Treatment Act of 2017

Client expense: $100,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Mens Rea Reform; Money Laundering (S. 1241, S.1757); Anti-Terrorism Information Sharing is Strength Act and related provisions; Corporate Transparency Bills (S.1454, S. 1717 and H.R. 3089); Financial Institution Security Act (H.R. 3439); Megabank Accountability & Consequences Act (H.R. 3937);CLOUD Act (H.R. 4943); Stop Enabling Sex Traffickers Act (S. 1693, H.R. 1865); Disclosing Foreign Influence Act (H.R. 4170); Stop the Importation and Trafficking of Synthetic Analogues Act (S. 1327, H.R. 2851); Ending the Fentanyl Crisis Act (S.2635); GRACE Act (S. 2471); Building America's Trust Act (S. 1757); Securing America's Future Act (H.R. 4760); Death penalty for drug dealers

Client expense: $15,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 714 Use of Medicinal Marihuana H.R. 715 Rescheduling of Marihuana H.R. 975 Controlled Substances Act Application to Marihuana H.R. 1781 Synthetic Opioids H.R. 1824 Federal and State Marijuana Policy Gap Reduction S. 581 Opioids Addiction Information in Medical Records S. 780 Federal and State Marijuana Policy Gap Reduction H.R. 2020 Rescheduling of Marijuana H.R. 2063 Opioid Dispensary Registration Training Condition S. 1078 FDA Opioid Approval Procedures S. 1079 FDA Opioid Approval and Revocation S. 1327 Controlled Substance Analogues Regulation H.R. 3374 Drunk Driving H.R. 3534 State Legalized Marijuana S. 1553 Schedule 1 Controlled Substances S. 1554 Controlled Substance Continuing Education S. 1689 Controlled Substances Act H.R. 3964 Registration Requirements for Prescribers of Opioids H.R. 4482 Opioid Abuse and Addiction S. 2008 Opioid Epidemic and Drug Sample Backlogs H.R. 4903 Opioid Usage Reduction Best Practices Study H.R. 4922 Fentanyl Analogues H.R. 5109 Opioid Epidemic Distribution of Resources S. 2437 Opioid Grant Program S. 2440 Opioid Epidemic S. 2535 Opioid Quotas **Issues lobbied without specific bill number: Workers' Compensation Medicare Set-Aside

Client expense: $1,220,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2019, provisions relating to NIH and drug abuse and treatment Drug abuse research and treatment related issues: H.R.1732, Synthetic Drug Control Act of 2017 H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA) H.R.3391, Medical Marijuana Research Act of 2017 S.2004, Combating the Opioid Epidemic Act S.1803, Marijuana Effective Drug Studies (MEDS) Act of 2017 S.2260, Opioids and STOP Pain Initiative Act S.2004, Combating the Opioid Epidemic Act H.R.5298, Modernizing Drug Enforcement Act of 2018 H.R.5311/S.2456, Comprehensive Addiction and Recovery Act or CARA 2.0 Act of 2018

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.

Client expense: Not reported · Firm income: $310,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2851/S. 1327, SITSA Act (re. new schedules and sentences for drug analogues); mandatory minimum sentencing reform; H.R. 3356, Prison Reform and Redemption Act (prison reform); oversight of Bureau of Prisons; halfway houses; compassionate release; H.R. 2435/S. 1134 (sentencing discretion for courts); S. 1917, Sentencing Reform and Corrections Act (sentencing and prison reform); S. 1994, CORRECTIONS Act (prison reform); H.R. 4261, SAFE Justice Act (sentencing and prison reform); S. 2471, GRACE Act (compassionate release); U.S. Sentencing Commission nominations

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE

H.R.1057-Synthetics Trafficking and Overdose Prevention Act of 2017 H.R.2200-Frederick Douglass Trafficking Victims Prevention and Protection Reauthorization Act of 2017 H.R.2851-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 S.372-Synthetics Trafficking and Overdose Prevention Act of 2017 S.1327-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017

Client expense: $672,362 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)

Alternatives to Opiates (ALTO) H.R.1057-Synthetics Trafficking and Overdose Prevention Act of 2017 H.R.1492-Medical Controlled Substances Transportation Act of 2017 H.R.2851-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017 H.R.3545-Overdose Prevention and Patient Safety (OPPS) Act S.372-Synthetics Trafficking and Overdose Prevention Act of 2017 S.1327-Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017

Client expense: $672,362 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)

H.R. 2851 and S. 1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 Public Law No: 114-145, Ensuring Patient Access and Effective Drug Enforcement Act of 2016

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE